MedTrace Logo

Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

NCT03553654 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2022-11-03

No results posted yet for this study

Summary

Prospective single arm study to evaluate a low-dose CT-based protocol for early detection of myocardial dysfunction in 50 cancer patients undergoing anthracycline-based chemotherapy.

Conditions

  • Neoplasms

Interventions

DIAGNOSTIC_TEST

low dose CT

CT-based protocol for detection of anthracycline-induced myocardial dysfunction at early stages

Sponsors & Collaborators

Principal Investigators

  • Anna Narezkina, MD · UCSD

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-09
Primary Completion
2021-12-12
Completion
2021-12-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553654 on ClinicalTrials.gov